MSK Innovations

MSK Innovations is excited to announce our lineup for December 4th's Pitch Event! Nanochon - Benjamin Holmes, CEO Nanochon is a medical device company focused on developing innovative cartilage repair technologies using advanced 3D printing and nanomaterial polymers. Orthomod LLC - David Kirschman, MD, CEO Orthomod is developing regenerative orthopedic implants to improve patient outcomes using novel structural biomaterials. ALLUMIN8 - Alyssa Huffman, CEO ALLUMIN8 is Introducing a new category of Therapeutic Orthopedic & Spine 3D Hardware designed to reduce global reoperation rates. Register today! https://lnkd.in/guVCJgMd #venturecapital #seriesA #fundraising #orthopedics #orthopedicsurgery #orthopedicimplants #medtech #spinesurgery Drue DeAngelis TJ Halvorson

Join us on December 4th at 2pm PST to hear from three more innovators in the MSK industry. Alyssa Huffman, CEO at ALLUMIN8, will present. Introducing a new category of Therapeutic Orthopedic & Spine 3D Hardware designed to reduce global reoperation rates. Our advanced porous solutions provide surgeons with innovative pathways to diagnose, treat, and heal through the devices, enhancing patient outcomes with the highest level of clinical evidence and cutting-edge technology. Register today! https://lnkd.in/g_cFYDBU #fundraising #medtech #orthopedics #orthopedicimplants #spine #spinehardware #orthopedicsurgery #spinesurgery #spinetechnology

Join us on December 4th at 2pm PST to hear from three more innovators in the MSK industry. David Kirschman, MD, CEO at Orthomod LLC, will present. Orthomod is developing regenerative orthopedic implants to improve patient outcomes using novel structural biomaterials. Orthomod addresses the limitations of existing orthopedic implants that lack both strength and bone-healing properties- leading to failure, costly revisions, and long recovery times. Its CAMP material promotes bone ingrowth and fusion while maintaining full load-bearing integrity, offering a durable, osteoactive alternative to materials like PEEK, titanium, or bone grafts in the $50B+ orthopedic implant market.?Orthomod currently has two FDA 510(k) applications pending for spinal and cranial applications, and will set a new standard for orthopedic solutions. Register today! https://lnkd.in/g_cFYDBU #fundraising #medtech #orthopedics #orthopedicimplants #spine #spinalimplants #orthopedicsurgery #biotech #bonehealing

Join us on December 4th at 2pm PST to hear from three more innovators in the MSK industry. Benjamin Holmes, CEO at Nanochon, will present. Nanochon is a medical device company focused on developing innovative cartilage repair technologies using advanced 3D printing and nanomaterial polymers. Their flagship product, the Chondrograft?, is designed to provide both immediate structural support and promote natural tissue regeneration for joint repair. Nanochon aims to revolutionize orthopedic care by offering less invasive, more durable alternatives to traditional joint replacement surgeries, improving recovery outcomes for patients, and addressing the cost and difficulty of the standards of care for sports medicine surgeons. Register today! https://lnkd.in/g_cFYDBU #fundraising #medtech #orthopedics #jointsurgery #jointrepair #jointreplacement #orthopedicsurgery cultivate(MD)

MSK Innovations is excited to announce our lineup for December 4th's Pitch Event! Nanochon - Benjamin Holmes, CEO Nanochon is a medical device company focused on developing innovative cartilage repair technologies using advanced 3D printing and nanomaterial polymers. Orthomod LLC - David Kirschman, MD, CEO Orthomod is developing regenerative orthopedic implants to improve patient outcomes using novel structural biomaterials. ALLUMIN8 - Alyssa Huffman, CEO ALLUMIN8 is Introducing a new category of Therapeutic Orthopedic & Spine 3D Hardware designed to reduce global reoperation rates. Register today! https://lnkd.in/guVCJgMd #venturecapital #seriesA #fundraising #orthopedics #orthopedicsurgery #orthopedicimplants #medtech #spinesurgery Drue DeAngelis TJ Halvorson

MSK Innovations is excited to announce our lineup for November 6th's Pitch Event! ZygoFix Ltd.?- Ofer Levy, CEO ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system?utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market. CytexOrtho?- Brad Estes, Ph.D., CEO CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options. INDIUS Medical Solutions?- Aditya Ingalhalikar, PhD, CEO INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution. Register today! https://lnkd.in/gEP5fZzK #venturecapital?#seriesA?#fundraising?#orthopedics?#orthopedicsurgery #scoliosis?#medtech #spinesurgery Drue DeAngelis TJ Halvorson

MSK Innovations is excited to announce our lineup for November 6th's Pitch Event! ZygoFix Ltd.?- Ofer Levy, CEO ZygoFix has developed a proprietary approach to spinal stabilization and spinal fusion. The company's zLOCK system?utilizes our spine’s natural anatomy for spinal stability. The system offers all around benefits to the $2.2 billion worldwide addressable spine market. CytexOrtho?- Brad Estes, Ph.D., CEO CytexOrtho is developing an absorbable orthopedic implant designed to treat early hip disease in young/active patients, offering a much-needed solution for a growing population that currently lacks effective treatment options. INDIUS Medical Solutions?- Aditya Ingalhalikar, PhD, CEO INDIUS has developed Patient Specific Growth Rods, an innovative solution for treating children with spinal scoliosis, reducing the need for multiple surgeries. INDIUS’s technology enables daily growth response, addressing a critical need in pediatric scoliosis care. The company holds global IP for this groundbreaking solution. Register today! https://lnkd.in/gEP5fZzK #venturecapital?#seriesA?#fundraising?#orthopedics?#orthopedicsurgery #scoliosis?#medtech #spinesurgery Drue DeAngelis TJ Halvorson

We are excited to introduce Chris Lyons as a panelist for the upcoming MSK Innovations Pitch Event on November 6th at 2:00 PM PST. With over 30 years of experience in the Musculoskeletal Industry, Chris brings a wealth of knowledge in M&A, fundraising, start-ups, and corporate growth. Chris is the founder of Southern Metrics Consulting (SMC), where he focuses on enhancing medical device organizations' understanding of multinational corporations' expectations to ensure successful exits. SMC works with disruptive client technologies, offering services in fundraising, due diligence planning, and strategic guidance. Previously, Chris led the Business Development division at Medtronic Spine & Biologics and began his career at Smith+Nephew after graduating from The University of Memphis. He has also been actively involved in the Southeast Medical Device Association (SEMDA) as the past chairman and a current board member. Don't miss out on this opportunity to hear from Chris and other industry experts at the MSK Innovations Pitch Event. Register now: https://lnkd.in/gEP5fZzK #MusculoskeletalIndustry #BusinessDevelopment #Fundraising #StartupStrategy #VentureCapital #PrivateEquity #MedicalDevices

We are excited to introduce Paul Saam as a panelist for the upcoming MSK Innovations Pitch Event on November 6th at 2:00 PM PST. With over 25 years of experience in the medical device industry, Paul brings extensive expertise in strategic planning, business development, and M&A integration. Currently, Paul serves as Director of Strategic Planning and Business Development at Zimmer Biomet, where he oversees multiple business units including Biologics, Extremities, Sports Medicine, Surgical, Trauma, Foot & Ankle, Bone Healing, and Connected Health. Since joining the company in 2008, he has successfully led numerous strategic initiatives including acquisitions, distribution arrangements, license agreements, and strategic partnerships. Paul also played key leadership roles in major integration efforts, including the Abbott Spine acquisition and the Zimmer Biomet merger. Previously, Paul held positions at Abbott Spine as Manager of Business Development and Product Manager. His career began in medical device startups, where he gained valuable experience as a Project Engineer at IsoStent and as a Corporate Strategist at Affinergy, Inc. Paul holds an Engineering degree from Harvey Mudd College and an MBA from the Fuqua School of Business at Duke University. Don't miss out on this opportunity to hear from Paul and other industry experts at the MSK Innovations Pitch Event. Register now: https://lnkd.in/gkrJfYAy #MusculoskeletalIndustry #BusinessDevelopment #Fundraising #StartupStrategy #VentureCapital #PrivateEquity #MedicalDevices

We are excited to introduce Paul Slosar, MD, MHCDS as a panelist for the upcoming MSK Innovations Pitch Event on November 6th at 2:00 PM PST. With 28 years of experience as an orthopedic spine surgeon in the San Francisco Bay area and extensive expertise in healthcare technology, Dr. Slosar brings a unique blend of clinical and business acumen to the panel. Currently, Dr. Slosar serves as a Partner at 46 Venture Capital, where he oversees the healthcare portfolio investments. He is also the Co-Founder and General Partner of the Physicians Capital Venture Fund and Founder/CEO of PS/md Consulting LLC, where he provides strategic advisory services to physician practices and healthcare companies. Previously, Dr. Slosar served as Chief Medical Officer at Titan Spine LLC for 11 years, leading to its successful acquisition by Medtronic in 2019. He has also held key leadership positions including Administrative Partner and President of his medical group from 2007-2020, Medical Director of the Spine Care Institute of San Francisco, and Director of Surgical Research at the San Francisco Spine Institute. His strategic guidance has contributed to several successful acquisitions, including Kyphon, Surgical Care Affiliates, and Relievant. Dr. Slosar holds a Master of Health Care Delivery Science from Dartmouth College, an MD from Rush University, and an Intensive Seminar Certificate in Value-Based Health Care from Harvard Business School. Don't miss out on this opportunity to hear from Paul and other industry experts at the MSK Innovations Pitch Event. Register now: https://lnkd.in/gEP5fZzK #MusculoskeletalIndustry #BusinessDevelopment #Fundraising #StartupStrategy #VentureCapital #PrivateEquity #MedicalDevices